Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
50°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xtl Biopharma ADR
(NQ:
XTLB
)
2.430
UNCHANGED
Streaming Delayed Price
Updated: 3:07 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.430
Bid (Size)
0.9200 (2)
Ask (Size)
3.680 (2)
Prev. Close
2.430
Today's Range
2.430 - 2.430
52wk Range
0.7500 - 4.990
Shares Outstanding
514,205,799
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million
August 14, 2024
From
XTL Biopharmaceuticals Ltd.
Via
GlobeNewswire
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 17, 2024
Via
Benzinga
Performance
YTD
+148.62%
+148.62%
1 Month
-11.31%
-11.31%
3 Month
+7.05%
+7.05%
6 Month
-13.83%
-13.83%
1 Year
+155.76%
+155.76%
More News
Read More
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
June 17, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 17, 2024
Via
InvestorPlace
XTL Entered Definitive Agreement to Acquire The Social Proxy
June 05, 2024
From
XTL Biopharmaceuticals Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 15, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 13, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 29, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 27, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 26, 2024
Via
InvestorPlace
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 20, 2024
Via
Benzinga
Dow Surges 350 Points; Fed Holds Rates Steady
March 20, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 20, 2024
Via
Benzinga
Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher
March 20, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Fossil Fuels
Interest Rates
US Equities
US Stocks Edge Lower Ahead Of Fed's Decision; General Mills Earnings Top Views
March 20, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
XTL To Aquire The Social Proxy
March 20, 2024
From
XTL Biopharmaceuticals Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 10, 2023
Via
Benzinga
XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel
October 20, 2023
From
XTL Biopharmaceuticals Ltd.
Via
GlobeNewswire
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
October 20, 2023
From
XTL Biopharmaceuticals Ltd.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.